Department of Animal Science, Iowa State University, Ames, IA, 50011, USA.
Department of Animal, Dairy, and Veterinary Science, Utah State University, Logan, UT, 84322, USA.
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae062.
Angus-cross steers (n = 144; 359 kg ± 13.4) were used to assess the effect of dietary Mn and steroidal implants on performance, trace minerals (TM) status, hepatic enzyme activity, hepatic gene expression, and serum metabolites. Steers (n = 6/pen) were stratified by BW in a 3 × 2 factorial. GrowSafe bunks recorded individual feed intake (experimental unit = steer; n = 24/treatment). Dietary treatments included (MANG; 8 pens/treatment; Mn as MnSO4): (1) no supplemental Mn (analyzed 14 mg Mn/kg DM; Mn0); (2) 20 mg supplemental Mn/kg DM (Mn20); (3) 50 mg supplemental Mn/kg DM (Mn50). Within MANG, steers received a steroidal implant treatment (IMP) on day 0: (1) no implant; NO; or (2) combination implant (Revalor-200; REV). Liver biopsies for TM analysis and qPCR, and blood for serum glucose, insulin, non-esterified fatty acids, and urea-N (SUN) analysis were collected on days 0, 20, 40, and 77. Data were analyzed as a randomized complete block with a factorial arrangement of treatments including fixed effects of Mn treatment (MANG) and implant (IMP) using PROC MIXED of SAS 9.4 using initial BW as a covariate. Liver TM, serum metabolite, enzyme activity, and gene expression data were analyzed as repeated measures. No MANG × IMP effects were noted (P ≥ 0.12) for growth performance or carcass characteristic measures. Dietary Mn did not influence final body weight, overall ADG, or overall G:F (P ≥ 0.14). Liver Mn concentration increased with supplemental Mn concentration (MANG; P = 0.01). An IMP × DAY effect was noted for liver Mn (P = 0.01) where NO and REV were similar on day 0 but NO cattle increased liver Mn from days 0 to 20 while REV liver Mn decreased. Relative expression of MnSOD in the liver was greater in REV (P = 0.02) compared to NO and within a MANG × IMP effect (P = 0.01) REV increased liver MnSOD activity. These data indicate current NASEM Mn recommendations are adequate to meet the demands of finishing beef cattle given a steroidal implant. Despite the roles of Mn in metabolic pathways and antioxidant defense, a basal diet containing 14 mg Mn/kg DM was sufficient for the normal growth of finishing steers. This study also provided novel insight into how implants and supplemental Mn influence genes related to arginine metabolism, urea synthesis, antioxidant capacity, and TM homeostasis as well as arginase and MnSOD activity in hepatic tissue of beef steers.
Angus 杂交阉牛(n=144;体重 359 千克±13.4)用于评估日粮锰和甾体植入物对性能、痕量矿物质(TM)状况、肝酶活性、肝基因表达和血清代谢物的影响。将阉牛(n=6/栏)按体重进行 3×2 析因分组。GrowSafe 铺位记录了个体饲料摄入量(实验单位=阉牛;n=24/处理)。日粮处理包括(MANG;8 个栏/处理;锰为 MnSO4):(1)不补充锰(分析值 14mg Mn/kg DM;Mn0);(2)补充 20mg Mn/kg DM(Mn20);(3)补充 50mg Mn/kg DM(Mn50)。在 MANG 中,阉牛在第 0 天接受甾体植入物处理(IMP):(1)不植入;NO;或(2)组合植入(Revalor-200;REV)。在第 0、20、40 和 77 天采集肝脏活检进行 TM 分析和 qPCR,以及采集血液进行血清葡萄糖、胰岛素、非酯化脂肪酸和尿素氮(SUN)分析。数据采用 SAS 9.4 的 PROC MIXED 作为随机完全区组进行分析,采用初始 BW 作为协变量,包括锰处理(MANG)和植入物(IMP)的固定效应。肝脏 TM、血清代谢物、酶活性和基因表达数据作为重复测量进行分析。未观察到 MANG×IMP 对生长性能或胴体特征指标的影响(P≥0.12)。日粮锰不影响最终体重、总日增重或总增重/饲料比(P≥0.14)。随着补充锰浓度的增加,肝脏锰浓度增加(MANG;P=0.01)。在肝脏锰中观察到 IMP×DAY 效应(P=0.01),NO 和 REV 在第 0 天相似,但 NO 牛在第 0 天至第 20 天期间肝脏锰增加,而 REV 肝脏锰减少。肝脏 MnSOD 的相对表达在 REV(P=0.02)中高于 NO,并且在 MANG×IMP 效应(P=0.01)内,REV 增加了肝脏 MnSOD 活性。这些数据表明,目前 NASEM 推荐的锰足以满足给予甾体植入物的育肥牛的需求。尽管锰在代谢途径和抗氧化防御中的作用,但基础日粮中含有 14mg Mn/kg DM 即可满足育肥阉牛的正常生长。本研究还提供了新的见解,了解植入物和补充锰如何影响与精氨酸代谢、尿素合成、抗氧化能力和 TM 稳态以及肝组织中精氨酸酶和 MnSOD 活性相关的基因。